Veracyte to Participate in Upcoming Investor Conferences
Veracyte (VCYT), a leading cancer diagnostics company, has announced its participation in two upcoming investor conferences in March. The company will present at the Raymond James 46th Annual Institutional Investors Conference in Orlando, FL on March 5th at 9:50 a.m. Eastern Time, and participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, FL on March 11th at 8:40 a.m. Eastern Time.
Live audio webcasts of both presentations will be accessible through Veracyte's investor relations website. Replay recordings will remain available for 90 days following each presentation.
Veracyte (VCYT), un'azienda leader nel settore della diagnostica oncologica, ha annunciato la sua partecipazione a due prossime conferenze per investitori a marzo. L'azienda presenterà al 46° Annual Institutional Investors Conference di Raymond James a Orlando, FL, il 5 marzo alle 9:50 ora orientale, e parteciperà a una chiacchierata informale al Leerink Partners Global Healthcare Conference a Miami, FL, l'11 marzo alle 8:40 ora orientale.
Le trasmissioni audio in diretta di entrambe le presentazioni saranno accessibili tramite il sito web delle relazioni con gli investitori di Veracyte. Le registrazioni delle riprese rimarranno disponibili per 90 giorni dopo ciascuna presentazione.
Veracyte (VCYT), una empresa líder en diagnóstico del cáncer, ha anunciado su participación en dos próximas conferencias para inversores en marzo. La empresa presentará en la 46ª Conferencia Anual de Inversores Institucionales de Raymond James en Orlando, FL, el 5 de marzo a las 9:50 a.m. hora del Este, y participará en un chat informal en la Conferencia Global de Salud de Leerink Partners en Miami, FL, el 11 de marzo a las 8:40 a.m. hora del Este.
Las transmisiones de audio en vivo de ambas presentaciones estarán disponibles a través del sitio web de relaciones con inversores de Veracyte. Las grabaciones de las repeticiones estarán disponibles durante 90 días después de cada presentación.
Veracyte (VCYT), 선도적인 암 진단 회사,가 3월에 열리는 두 개의 투자자 회의에 참여한다고 발표했습니다. 이 회사는 3월 5일 오전 9시 50분(동부 표준시)에 플로리다주 올랜도에서 열리는 레이몬드 제임스 제46회 연례 기관 투자자 회의에서 발표하고, 3월 11일 오전 8시 40분(동부 표준시)에 플로리다주 마이애미에서 열리는 리린크 파트너스 글로벌 헬스케어 회의에서 대화에 참여합니다.
두 발표의 라이브 오디오 웹캐스트는 Veracyte의 투자자 관계 웹사이트를 통해 접근할 수 있습니다. 각 발표 후 90일 동안 다시보기 녹음이 제공됩니다.
Veracyte (VCYT), une entreprise leader dans le domaine du diagnostic du cancer, a annoncé sa participation à deux prochaines conférences pour investisseurs en mars. L'entreprise fera une présentation lors de la 46e Conférence Annuelle des Investisseurs Institutionnels de Raymond James à Orlando, FL, le 5 mars à 9h50, heure de l'Est, et participera à une discussion informelle lors de la Conférence Mondiale sur la Santé de Leerink Partners à Miami, FL, le 11 mars à 8h40, heure de l'Est.
Les diffusions audio en direct des deux présentations seront accessibles via le site web des relations investisseurs de Veracyte. Les enregistrements des rediffusions resteront disponibles pendant 90 jours après chaque présentation.
Veracyte (VCYT), ein führendes Unternehmen im Bereich der Krebsdiagnostik, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im März angekündigt. Das Unternehmen wird am 5. März um 9:50 Uhr Eastern Time auf der 46. jährlichen Institutional Investors Conference von Raymond James in Orlando, FL, präsentieren und an einem Fireside-Chat auf der Leerink Partners Global Healthcare Conference in Miami, FL, am 11. März um 8:40 Uhr Eastern Time teilnehmen.
Live-Audio-Webcasts beider Präsentationen sind über die Investor-Relations-Website von Veracyte zugänglich. Aufzeichnungen der Wiederholungen bleiben 90 Tage nach jeder Präsentation verfügbar.
- None.
- None.
-
Raymond James 46th Annual Institutional Investors Conference –
Orlando, FL
Presentation on March 5th at 9:50 a.m. Eastern Time
-
Leerink Partners Global Healthcare Conference –
Miami, FL
Fireside Chat on March 11th at 8:40 a.m. Eastern Time
Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219418154/en/
Investors:
Shayla Gorman
investors@veracyte.com
(619) 393-1545
Media:
Tracy Morris
media@veracyte.com
(650) 380-4413
Source: Veracyte, Inc.
FAQ
When is Veracyte (VCYT) presenting at the Raymond James Conference?
What time is Veracyte's (VCYT) fireside chat at the Leerink Partners Conference?
How long will Veracyte's (VCYT) conference presentation webcasts be available?
Where can investors access Veracyte's (VCYT) conference presentation webcasts?
